Zuber Samuel M, Grikscheit Tracy C
Division of Pediatric Surgery, Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90027, USA.
Division of Pediatric Surgery, Children's Hospital Los Angeles, Keck School of Medicine of the University of Southern California, Los Angeles, CA 90027, USA.
J Pediatr Surg. 2019 Jan;54(1):16-20. doi: 10.1016/j.jpedsurg.2018.10.027. Epub 2018 Oct 5.
Pediatric surgeons are ideal allies for the translation of basic science including stem cell therapies. In the spirit of Robert E. Gross, of applying creative solutions to pediatric problems with technical expertise, we describe the impending cellular therapies that may be derived from stem and progenitor cells. Understanding the types and capabilities of stem and progenitor cells is important for pediatric surgeons to join and facilitate progress for babies. We are developing an induced pluripotent stem cell therapy for enteric neuropathies such as Hirschsprung disease that might be helpful for children in the near future. Our goals, which we hope to share with other surgeons and scientists, include working to establish safe clinical trials and meeting regulatory standards in a thoughtful way that balances patients need and unknown risks.
小儿外科医生是包括干细胞疗法在内的基础科学转化的理想盟友。本着罗伯特·E·格罗斯的精神,即运用专业技术为儿科问题提供创造性解决方案,我们描述了可能源自干细胞和祖细胞的即将出现的细胞疗法。了解干细胞和祖细胞的类型及能力对于小儿外科医生参与并推动针对婴儿的治疗进展非常重要。我们正在开发一种针对诸如先天性巨结肠等肠道神经病变的诱导多能干细胞疗法,这在不久的将来可能会对儿童有所帮助。我们希望与其他外科医生和科学家共同实现的目标包括努力建立安全的临床试验,并以一种兼顾患者需求和未知风险的周全方式达到监管标准。